Impact of Age of Heart Transplant Program on Patient Survival and Post-Transplant Outcomes

IF 1.9 4区 医学 Q2 SURGERY Clinical Transplantation Pub Date : 2024-07-01 DOI:10.1111/ctr.15387
David T. Majure, Gabriel Sayer, Kevin J. Clerkin, Maria G. Karas, Mandisa Jones, Evelyn M. Horn, Yoshifumi Naka, Nir Uriel
{"title":"Impact of Age of Heart Transplant Program on Patient Survival and Post-Transplant Outcomes","authors":"David T. Majure,&nbsp;Gabriel Sayer,&nbsp;Kevin J. Clerkin,&nbsp;Maria G. Karas,&nbsp;Mandisa Jones,&nbsp;Evelyn M. Horn,&nbsp;Yoshifumi Naka,&nbsp;Nir Uriel","doi":"10.1111/ctr.15387","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>The relationship between age of a heart transplant (HT) program and outcomes has not been explored.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We performed a retrospective cohort analysis of the United Network for Organ Sharing database of all adult HTs between 2009 and 2019. For each patient, we created a variable that corresponded to program age: new (&lt;5), developing (≥5 but &lt;10) and established (≥10) years.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of 20 997 HTs, 822 were at new, 908 at developing, and 19 267 at established programs. Patients at new programs were significantly more likely to have history of cigarette smoking, ischemic cardiomyopathy, and prior sternotomy. These programs were less likely to accept organs from older donors and those with a history of hypertension or cigarette use. As compared to patients at new programs, transplant patients at established programs had less frequent rates of treated rejection during the index hospitalization (HR 0.43 [95% CI, 0.36–0.53] <i>p</i> &lt; 0.001) and at 1 year (HR 0.58 [95% CI, 0.49–0.70], <i>p</i> &lt; 0.001), less frequently required pacemaker implantations (HR 0.50 [95% CI, 0.36–0.69], <i>p</i> &lt; 0.001), and less frequently required dialysis (HR 0.66 [95% CI, 0.53–0.82], <i>p</i> &lt; 0.001). However, there were no significant differences in short- or long-term survival between the groups (log-rank <i>p</i> = 0.24).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Patient and donor selection differed between new, developing, and established HT programs but had equivalent survival. New programs had increased likelihood of treated rejection, pacemaker implantation, and need for dialysis. Standardized post-transplant practices may help to minimize this variation and ensure optimal outcomes for all patients.</p>\n </section>\n </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Transplantation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ctr.15387","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The relationship between age of a heart transplant (HT) program and outcomes has not been explored.

Methods

We performed a retrospective cohort analysis of the United Network for Organ Sharing database of all adult HTs between 2009 and 2019. For each patient, we created a variable that corresponded to program age: new (<5), developing (≥5 but <10) and established (≥10) years.

Results

Of 20 997 HTs, 822 were at new, 908 at developing, and 19 267 at established programs. Patients at new programs were significantly more likely to have history of cigarette smoking, ischemic cardiomyopathy, and prior sternotomy. These programs were less likely to accept organs from older donors and those with a history of hypertension or cigarette use. As compared to patients at new programs, transplant patients at established programs had less frequent rates of treated rejection during the index hospitalization (HR 0.43 [95% CI, 0.36–0.53] p < 0.001) and at 1 year (HR 0.58 [95% CI, 0.49–0.70], p < 0.001), less frequently required pacemaker implantations (HR 0.50 [95% CI, 0.36–0.69], p < 0.001), and less frequently required dialysis (HR 0.66 [95% CI, 0.53–0.82], p < 0.001). However, there were no significant differences in short- or long-term survival between the groups (log-rank p = 0.24).

Conclusion

Patient and donor selection differed between new, developing, and established HT programs but had equivalent survival. New programs had increased likelihood of treated rejection, pacemaker implantation, and need for dialysis. Standardized post-transplant practices may help to minimize this variation and ensure optimal outcomes for all patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
心脏移植项目的年龄对患者存活率和移植后效果的影响。
背景:心脏移植(HT)项目的年龄与结果之间的关系尚未得到探讨:我们对器官共享联合网络(United Network for Organ Sharing)数据库中 2009 年至 2019 年期间的所有成人心脏移植手术进行了回顾性队列分析。对于每位患者,我们创建了一个与项目年龄相对应的变量:新患者(结果:在 20 997 例 HT 中,有 8 例为新患者):在 20 997 例 HT 中,822 例为新项目,908 例为发展中项目,19 267 例为成熟项目。新项目的患者更有可能有吸烟史、缺血性心肌病和胸骨切开术前病史。这些项目不太可能接受年龄较大的捐献者和有高血压或吸烟史的捐献者的器官。与新项目的患者相比,成熟项目的移植患者在指标住院期间发生治疗性排斥反应的频率较低(HR 0.43 [95% CI, 0.36-0.53] p 结论:新项目和成熟项目的患者和供体选择不同:新的移植项目、发展中的移植项目和成熟的移植项目在患者和供体的选择上有所不同,但存活率相当。新项目出现治疗性排斥反应、起搏器植入和透析需求的可能性增加。标准化的移植后实践可能有助于最大限度地减少这种差异,并确保所有患者都能获得最佳治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Transplantation
Clinical Transplantation 医学-外科
CiteScore
3.70
自引率
4.80%
发文量
286
审稿时长
2 months
期刊介绍: Clinical Transplantation: The Journal of Clinical and Translational Research aims to serve as a channel of rapid communication for all those involved in the care of patients who require, or have had, organ or tissue transplants, including: kidney, intestine, liver, pancreas, islets, heart, heart valves, lung, bone marrow, cornea, skin, bone, and cartilage, viable or stored. Published monthly, Clinical Transplantation’s scope is focused on the complete spectrum of present transplant therapies, as well as also those that are experimental or may become possible in future. Topics include: Immunology and immunosuppression; Patient preparation; Social, ethical, and psychological issues; Complications, short- and long-term results; Artificial organs; Donation and preservation of organ and tissue; Translational studies; Advances in tissue typing; Updates on transplant pathology;. Clinical and translational studies are particularly welcome, as well as focused reviews. Full-length papers and short communications are invited. Clinical reviews are encouraged, as well as seminal papers in basic science which might lead to immediate clinical application. Prominence is regularly given to the results of cooperative surveys conducted by the organ and tissue transplant registries. Clinical Transplantation: The Journal of Clinical and Translational Research is essential reading for clinicians and researchers in the diverse field of transplantation: surgeons; clinical immunologists; cryobiologists; hematologists; gastroenterologists; hepatologists; pulmonologists; nephrologists; cardiologists; and endocrinologists. It will also be of interest to sociologists, psychologists, research workers, and to all health professionals whose combined efforts will improve the prognosis of transplant recipients.
期刊最新文献
ChatGPT Solving Complex Kidney Transplant Cases: A Comparative Study With Human Respondents Interplay of Donor–Recipient Relationship and Donor Race in Living Liver Donation in the United States Successful Kidney Transplantation Despite Therapeutic Anticoagulation—Effective Apixaban Elimination by Hemoadsorption Subclinical Pancreas Rejection on Protocol Biopsy Within the First Year of Simultaneous Pancreas Kidney Transplant External Validation of a Limited Sampling Strategy for the Estimation of Mycophenolic Acid Exposure Between Different Assay Methods: PETINIA and HPLC Methods
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1